US4379785AExpiredUtility

Heterocyclic substituted sulfonyl ureas, and their use

97
Assignee: HOECHST AGPriority: Dec 19, 1979Filed: Dec 17, 1980Granted: Apr 12, 1983
Est. expiryDec 19, 1999(expired)· nominal 20-yr term from priority
A61P 3/10A61P 3/08C07D 217/24C07D 211/76C07D 207/27C07D 209/46C07D 223/10C07D 207/38
97
PatentIndex Score
159
Cited by
11
References
6
Claims

Abstract

What are disclosed are sulfonyl ureas of the formula <IMAGE> in which R1, X and Y are as defined in the specification, and their physiologically acceptable salts, pharmaceutical formulations on the basis of these compounds, and their use in the treatment of diabetes.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A sulfonyl urea of the formula ##STR12## or a physiologically acceptable salt thereof, wherein X is alkylene or alkenylene having from 3 to 6 carbon atoms, optionally substituted by up to 3 alkyl groups each having from 1 to 4 carbon atoms, or by phenyl; or the group ##STR13##  is a bicyclic system of the formula ##STR14##   and Y is alkylene having 2 or 3 carbon atoms;   R 1  is alkyl having from 4 to 6 carbon atoms, cycloalkyl, alkylcycloalkyl, dialkylcycloalkyl, cycloalkylalkyl, cycloalkenyl, or alkylcycloalkenyl in each case having 4 to 9 carbon atoms, or is methylcyclopentylmethyl, cyclohexenylmethyl, chlorocyclohexyl, methoxycyclohexyl, bicycloheptyl, bicycloheptenyl, bicycloheptylmethyl, bicycloheptenylmethyl, bicyclooctyl, nortricyclyl, adamantyl, or benzyl.   
     
     
       2. A compound as in claim 1 which is N-(4-[2-(3,4-dimethyl-2-oxo-3-pyrroline-1-carboxamido)-ethyl]-benzenesulfonyl)-N'-4-methyl-cyclohexyl-urea. 
     
     
       3. A compound as in claim 1 which is N-(4-[2-(3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)-ethyl]-benzenesulfonyl)-N'-4-methyl-cyclohexyl-urea. 
     
     
       4. A compound as in claim 1 which is N-(4-[2-(3,4-dimethyl-2-oxo-3-pyrroline-1-carboxamido)-ethyl]-benzenesulfonyl)-N'-4-ethyl-cyclohexyl-urea. 
     
     
       5. A pharmaceutical composition for lowering the blood sugar level, which comprises a hypoglycemically effective amount of a sulfonyl urea or salt thereof as in claim 1 in combination with a pharmaceutically acceptable carrier therefor. 
     
     
       6. A method for lowering the blood sugar level in a patient suffering from diabetes, which comprises orally administering a hypoglycemically effective amount of a sulfonyl urea or salt thereof as claimed in claim 1.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.